retatrutide mechanism glp-1 gip glucagon triple agonist Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor

Description

These injections work by regulating appetite, helping patients feel fuller longer, and reducing cravings

Its interesting because when we go back and look on the cover of our annual report from that year, theres a patient, Maria, and shes talking about her experience with Byetta, the brand name for exendin

Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey

Given all these unknowns, it may be best for Congress to pump the brakes on expanding GLP-1s in Medicare before we have a better understanding of their full value and a way to pay for it.

But for many Miami women with PCOS, theyre providing that extra boost needed to overcome the hormonal hurdles that have held them back and the lifestyle changes are being met with open arms